|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Detonation behavior of emulsion explosives显示文摘 | Lee Jaimin Per-Anders Persson | | 0，，05： | 1 |
| 2 | Human blood plasma-based electronic integrated circuit amplifier configuration显示文摘Dear Editor:There is accumulating evidence that human blood electronic circuit components and their application circuits become more and more important to cyborg implant/engineering,man-machine interface,human disease detection and healing,and artificial brain evolution[1-5].Here,we report the first development of human plasma-based amplifier circuit in the discrete as well as integrated circuit(IC)configuration mode.Electrolytes in the human blood contain an enormous number of charge carriers such as positive and negative molecule/atom ions,which are electri- | Shiv Prasad Kosta Manthan Manavadaria Killol Pandya Yogesh.Prasad Kosta Shakti Kosta Harsh Mehta Jaimin Patel | 2013 | The Journal of Biomedical Research2013，27，6： | 1 |
| 3 | Asymmetric responses of highway travel demand to changes in fuel price: An explanation via fuel price uncertainty显示文摘 | Yongjae Kwon Jaimin Lee | 2014 | Transportation Research Part A2014，，： | 1 |
| 4 | Intra--Industry Trade and tariff rates of Korea and China显示文摘 | Jaimin LEE Sangyong HAN | 2010 | China Economic Re- view2010，，4： | 1 |
| 5 | Intra-Industry Trade and tariff rates of Korea and China显示文摘 | Jaimin LEE Sangyong HAN | 2008 | China Economic Review2008，，4： | 1 |
| 6 | Acute respiratory distress syndrome:Predictors of noninvasive ventilation failure and intensive care unit mortality in clinical practice Original Research Article显示文摘 | Rajesh Chawla Jaimin Mansuriya Nikhil Modi | 2016 | Journal of Critical Care2016，31，1： | 1 |
| 7 | Programmed death 1 (PD-1) and ligand (PD-L1) inhibitors in head and neck squamous cell carcinoma: A meta-analysis显示文摘Background: PD-1 and PD-L1 inhibitors have emerged as promising treatments for patients with head and neck squamous cell carcinoma (HNSCC).Methods: Systematic review and meta-analysis of PD-1 and PD-L1 inhibitors in HNSCC. Outcomes: median overall survival (mOS), median progression-free survival (mPFS), Response Evaluation Criteria in Solid Tumors (RECIST) and treatment-related adverse events (TRAEs).Results: Eleven trials reported data on 1088 patients (mean age: 59.9 years, range: 18-90). The total mOS was 7.97 months (range: 6.0-16.5). Mean mPFS for all studies was 2.84 months (range: 1.9-6.5). PD-1 inhibitors had a lower rate of RECIST Progressive Disease than PD-L1 inhibitors (42.61%, 95% confidence interval [CI]: 36.29-49.06 vs. 56.79%, 95% CI: 49.18-64.19,P < 0.001). The rate of TRAEs of any grade (62.7%, 95% CI: 59.8-65.6) did not differ.Conclusions: Meta-analysis shows the efficacy of PD-1 and PD-L1 inhibitors in HNSCC and suggests a possible difference in certain RECIST criterion between PD-1 and PD-L1 inhibitors. Future work to investigate the clinical significance of these findings is warranted. | Dylan A.Levy Jaimin J.Patel Shaun A.Nguyen W.Nicholas Jungbauer David M.Neskey Ezra E.W.Cohen Chrystal M.Paulos John A.Kaczmar Hannah M.Knochelmann Terry A.Day | 2022 | World Journal of Otorhinolaryngology-Head and Neck Surgery2022，8，3： | 0 |
| 8 | Chaebol Firms' Real and Accrual-Based Earnings Management in the Pre-and Post-Asian Financial Crisis Periods显示文摘 | Cho Jungeun Goh Jaimin Lee Jaehong | 2012 | Journal of Modern Accounting and Auditing2012，8，7： | 0 |
| 9 | Hyperbaric oxygen therapy in malignant otitis externa:A systematic review of the literature显示文摘Objective:To review the role of adjuvant hyperbaric oxygen therapy(HBOT)in the treatment of malignant otitis externa(MOE).Data sources:PubMed,Scopus,Web of Science,Science Direct,and Cochrane Library were searched for the following concepts:“hyperbaric oxygen”and“malignant or necrotizing otitis externa.”Methods:Studies were included if they contained(1)patients with reported evidence of MOE,(2)employment of adjuvant HBOT,(3)details on patients’medical condition,and(4)documented survival outcomes.Extracted information included patient demographics,underlying medical conditions,infectious etiology,signs and symptoms,medical and surgical treatments,duration of medical treatment,mean follow up time,HBOT setting,number of HBOT sessions,complications,survival rate,and all-cause mortality.Results:A total of 16 studies comprising 58 patients(mean age 68.0 years)were included.Diabetes was present in 94.7%of cases and Pseudomonas spp(64.3%)was the most common infectious agent.Cranial nerve VII was involved in 55.2%of cases.Overall,the disease cure rate with adjuvant HBOT was 91.4%and all-cause mortality was 8.6%.Among those who had cranial nerve VII involvement,72.0%had return of function and 93.8%of them survived.Conclusion:HBOT may be an effective treatment option for refractory or advanced MOE but its efficacy remains unproven due to lack of strong scientific evidence.However,its therapeutic value should not be underestimated given good results and few adverse events reported in this study. | Young Jae Byun Jaimin Patel Shaun A.Nguyen Paul R.Lambert | 2021 | World Journal of Otorhinolaryngology-Head and Neck Surgery2021，7，4： | 0 |
| 10 | Cochlear implantation in patients with Meniere’s disease:A systematic review显示文摘Background:Meniere’s disease(MD)is an idiopathic disorder of the inner ear,which manifests as cochleo-vestibular dysfunction.Hearing loss will progress to a profound levelin a subset of patients with MD,and vestibular interventions can independently cause loss of hearing.The aim of this study was to systematically review the published literature describing the safety and efficacy of CI in patients with MD.Materials and methods:A systematic literature review was conducted in accordance PRISMA guidelines to identify articles that assessed at least one functional outcome in patients with MD who underwent CI.Demographic information,disease history,MD symptoms,outcomes measures,and complications related to CI were extracted from included studies.Results:In total,17 studies were included,and 182 patients with MD underwent CI.The weighted-mean age was 61.9 years(range 27-85).Study objective and methodology varied,and there was significant heterogeneity in CI outcome measures reported.In total,179(98.3%)of 182 patients reported objective improvements in at least one hearing metric after CI.A total of 69 patients(37.9%)reported vertigo or severe dizziness prior to CI,compared to 22 patients(15.4%)postoperatively.Two studies reported significant reductions in postoperative Tinnitus Handicap Inventory score(THI).Quality of life assessments varied between studies.Complications rates were low with only nine patients(4.9%)reporting a serious CI-related complication.Conclusions:This systematic review evaluated 17 studies describing the safety and efficacy of CI in patients with MD and encountered many challenges due to small sample sizes,and heterogeneity in study design and outcomes measured.Despite these limitations,this study of 182 patients is to the best of our knowledge the largest systematic review evaluating the safety and efficacy of CI in MD.The results of this study support the need for a standardized approach to evaluating outcomes of CI in patients with MD in future studies. | Vincent M.Desiato Jaimin J.Patel Shaun A.Nguyen Ted A.Meyer Paul R.Lambert | 2021 | World Journal of Otorhinolaryngology-Head and Neck Surgery2021，7，4： | 0 |
| 11 | Do Auditors Postpone Reporting in Response to Insider Trading? A Korean Perspective显示文摘 | Sungkyu Sohn Kiwi Chung Jaimin Goh | 2011 | Journal of Modern Accounting and Auditing2011，7，7： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员